Blog

Sourcing Better PDX Models with a Streamlined “Clinic-to-Bench” Pipeline

Discover how XenoSTART’s clinic-to-bench pipeline delivers more clinically relevant PDX models, real-world patient data, and accelerated drug development. Patient-derived xenograft

Read more   →

Thomas' Patient Story

Together in the Fight Against Cancer: Thomas’ Story of Community and Care

“I was thinking about this the other night, one of the things that changed was I stopped flossing, because I

Read more   →

Malignant Hematology Blog Banner

Breaking Barriers in Blood Cancer Treatment: Insights on the Future of Malignant Hematology

A recent START webinar titled Malignant Hematology: Advancing Treatment in Blood Cancers, provided an in-depth look into the current advancements

Read more   →

Advancing ADC Development

Advancing ADC Development: Expert Panel Explores Current Landscape and Future Opportunities

Antibody-drug conjugates (ADCs) are among the most promising innovations in cancer treatment today, combining the targeting precision of monoclonal antibodies

Read more   →

Dr. Moreno Wearables Blog

Wearable Technology in Early-Phase Cancer Trials: Advancing Objective Performance Measures

The integration of wearable technology into early-phase cancer trials represents a pivotal moment in oncology research, offering the ability to

Read more   →

Why Adpative

Why Adaptive Clinical Trials in Community Settings are the Future of Cancer Research

Randomized clinical trials (RCTs) began in the 1940s with streptomycin’s evaluation against tuberculosis. Since then, RCTs have been the foundation

Read more   →